deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03148132

VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP

Comparison of the Vascular Endothelial Growth Factor Serum Concentrations After Intravitreal Use of Bevacizumab or Ranibizumab as a Treatment for Type 1 Retinopathy of Prematurity

Sponsor: Hospital Central Dr. Ignacio Morones Prieto

Conditions Eye Diseases Premature Birth Retinal Disease Retinopathy of Prematurity Both Eyes
Interventions Bevacizumab Injection Ranibizumab Ophthalmic
Updated 10 times since 2017 Last updated: Jan 8, 2019 Started: May 23, 2017 Primary completion: Aug 30, 2018 Completion: Aug 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Eye Diseases and Premature Birth, this trial is completed. The trial is conducted by Hospital Central Dr. Ignacio Morones Prieto and has accumulated 10 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jun 2017 – ~Jul 2017 · 30 days · monthly snapshotNot Yet Recruiting~Jul 2017 – ~Aug 2017 · 31 days · monthly snapshotNot Yet Recruiting~Aug 2017 – ~Sep 2017 · 31 days · monthly snapshotRecruiting~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotRecruiting~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotRecruiting~Feb 2019 – ~Jan 2021 · 23 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Feb 2019 — Jan 2021 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

▶ Show 5 earlier versions

  1. Jun 2018 — Feb 2019 [monthly]

    Recruiting PHASE4

  2. Sep 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

  3. Aug 2017 — Sep 2017 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  4. Jul 2017 — Aug 2017 [monthly]

    Not Yet Recruiting PHASE4

  5. Jun 2017 — Jul 2017 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hospital Central Dr. Ignacio Morones Prieto
  • Universidad Autonoma de San Luis Potosí
Data source: Universidad Autonoma de San Luis Potosí

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations